Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)
China · Delayed Price · Currency is CNY 10.35
-0.03 (-0.29%)
Jul 3, 2026, 3:00 PM CST
SHA:603520 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,538 | 4,121 | 3,810 | 4,823 | 6,694 | 15,886 | |
Market Cap Growth | -0.67% | 8.17% | -21.00% | -27.95% | -57.86% | -1.32% |
Enterprise Value | 7,279 | 6,484 | 5,711 | 7,239 | 8,716 | 17,059 |
Last Close Price | 10.35 | 9.17 | 8.36 | 13.46 | 18.48 | 43.32 |
PE Ratio | 269.49 | 402.90 | - | 109.03 | - | 49.07 |
Forward PE | 35.69 | 29.84 | 17.38 | 23.53 | 23.90 | 37.04 |
PS Ratio | 1.84 | 1.69 | 1.62 | 2.20 | 3.14 | 7.94 |
PB Ratio | 1.76 | 1.61 | 1.45 | 2.74 | 3.78 | 7.17 |
P/TBV Ratio | 2.41 | 2.21 | 1.98 | 4.66 | 6.38 | 11.16 |
P/FCF Ratio | - | - | - | - | - | 77.51 |
P/OCF Ratio | - | 1123.90 | 19.69 | 108.25 | - | 31.22 |
EV/Sales Ratio | 2.95 | 2.65 | 2.43 | 3.30 | 4.09 | 8.53 |
EV/EBITDA Ratio | 20.94 | 20.15 | 20.17 | 21.86 | 29.25 | 28.69 |
EV/EBIT Ratio | 69.73 | 77.74 | 90.98 | 47.76 | 62.64 | 38.67 |
EV/FCF Ratio | - | - | - | - | - | 83.23 |
Debt / Equity Ratio | 1.18 | 1.16 | 1.01 | 1.74 | 1.57 | 0.86 |
Debt / EBITDA Ratio | 8.76 | 9.21 | 9.33 | 9.23 | 9.29 | 3.20 |
Debt / FCF Ratio | - | - | - | - | - | 9.31 |
Net Debt / Equity Ratio | 1.06 | 1.00 | 0.78 | 1.42 | 1.20 | 0.48 |
Net Debt / EBITDA Ratio | 7.88 | 7.93 | 7.26 | 7.52 | 7.11 | 1.79 |
Net Debt / FCF Ratio | -6.85 | -9.60 | -7.16 | -11.24 | -3.85 | 5.18 |
Asset Turnover | 0.40 | 0.40 | 0.41 | 0.41 | 0.42 | 0.43 |
Inventory Turnover | 1.76 | 1.72 | 1.70 | 1.79 | 2.59 | 2.38 |
Quick Ratio | 0.48 | 0.41 | 0.39 | 0.36 | 0.50 | 0.81 |
Current Ratio | 1.02 | 0.93 | 0.83 | 0.77 | 0.79 | 1.09 |
Return on Equity (ROE) | 0.64% | 0.40% | -2.23% | 2.52% | -3.61% | 16.17% |
Return on Assets (ROA) | 1.04% | 0.85% | 0.68% | 1.75% | 1.71% | 5.93% |
Return on Invested Capital (ROIC) | 1.83% | 1.70% | 1.40% | 3.66% | 3.88% | 12.20% |
Return on Capital Employed (ROCE) | 2.60% | 2.20% | 1.90% | 5.90% | 5.50% | 14.70% |
Earnings Yield | 0.37% | 0.25% | -1.29% | 0.92% | -1.13% | 2.04% |
FCF Yield | -8.80% | -6.44% | -7.54% | -4.60% | -8.22% | 1.29% |
Dividend Yield | 2.90% | 3.27% | 1.80% | - | 2.71% | 0.82% |
Payout Ratio | 850.57% | 1427.19% | - | 442.32% | - | 62.08% |
Buyback Yield / Dilution | -9.90% | -24.99% | -20.25% | 1.31% | -0.10% | -3.05% |
Total Shareholder Return | -7.01% | -21.72% | -18.46% | 1.31% | 2.60% | -2.23% |